Severe Preeclampsia Recurrence: What Clinicians Must Know
A recent large cohort study provides definitive data on the risk of recurrent severe preeclampsia, HELLP syndrome, and eclampsia. Hypertensive disorders of pregnancy cause substantial maternal and neonatal morbidity worldwide. Consequently, obstetricians frequently counsel patients regarding their future reproductive risks. This study analyzed over 560,000 patients to establish precise recurrence rates based on prior disease severity and gestational age.
Risk of Recurrent Severe Preeclampsia and Early-Onset Disease
The researchers observed that 14.9% of women with severe hypertensive disorders in an index pregnancy developed severe disease again. Furthermore, the timing of onset during the first pregnancy significantly altered recurrence rates. Patients with severe disease before 28 weeks faced a 22.9% risk of severe recurrence in their next pregnancy. In addition, these patients had an extraordinary 184-fold increased relative risk of developing recurrent disease before 28 weeks. Therefore, early-onset disease serves as a powerful predictor of future severe complications.
Recurrence Patterns for HELLP Syndrome and Eclampsia
Specific hypertensive phenotypes also demonstrated distinct recurrence trajectories in subsequent pregnancies. For instance, individuals with a history of HELLP syndrome had an 11.5% risk of developing severe hypertensive disorders later. Moreover, their risk of experiencing recurrent HELLP syndrome specifically was 4.6%. Similarly, patients with prior eclampsia had an 11.0% risk of severe hypertensive disease and a 1.1% risk of repeat eclampsia. Although recurrent eclampsia occurred infrequently, the relative risk remained forty times higher than in unaffected controls.
Clinical Implications and Patient Counseling Strategies
These findings offer crucial evidence for preconception counseling and antenatal planning. First, clinicians should identify women with prior early-onset severe disease as ultra-high-risk patients. Next, obstetricians must initiate prophylactic low-dose aspirin early in subsequent pregnancies according to established guidelines. Furthermore, frequent blood pressure monitoring and uterine artery Doppler assessments help track disease progression. Consequently, structured surveillance protocols can improve maternal and perinatal outcomes substantially.
Frequently Asked Questions
Q1: What is the overall recurrence rate for severe preeclampsia?
The overall recurrence rate for severe hypertensive disorders of pregnancy is approximately 14.9%.
Q2: How does gestational age at index diagnosis impact recurrence risk?
Patients who develop severe disease before 28 weeks face the highest risk, with a 22.9% recurrence rate.
Q3: What is the risk of recurrent HELLP syndrome?
Patients with prior HELLP syndrome have a 4.6% risk of recurrent HELLP and an 11.5% risk of severe hypertensive disease.
References
- Trawick E et al. Risk of Recurrent Severe Preeclampsia, HELLP (Hemolysis, Elevated Liver Enzymes, and Low Platelet Count) Syndrome, and Eclampsia in a Subsequent Pregnancy. Obstet Gynecol. 2026 Aug 20. doi: 10.1097/AOG.0000000000006398. PMID: 42623674.
- American College of Obstetricians and Gynecologists. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237-e260.
- Sibai BM. Preeclampsia recurrence and prevention. Semin Perinatol. 2007;31(3):135-141.
